Evidence map›Paper›PMID 41646567›Full record

ArticleCureus2026

Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Presenting After Long-Term Antihypertensive Therapy: A Case Report.

Mohammed Khalid, Shifa Nafis

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammed KhalidInternal Medicine, Amina Hospital, Ajman, ARE.
Shifa NafisMedicine, Ajman University, Ajman, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angioedema involving the airway is a serious medical condition that requires prompt recognition and treatment to prevent significant morbidity and mortality. Angioedema associated with angiotensin-converting enzyme (ACE) inhibitors can occur at any stage of therapy. While many patients develop symptoms early in treatment, others may remain asymptomatic for months or even years. Diagnosis is primarily clinical and relies on the presence of non-itchy, non-urticarial swelling in a patient receiving an ACE inhibitor, as there is no definitive laboratory test for ACE inhibitor-induced angioedema. ACE inhibitor-related angioedema is one of the most common types of non-histaminergic angioedema encountered in clinical practice. Here, we present a case of angioedema affecting the lips and tongue that developed years after ACE inhibitor initiation, resulting in difficult airway management and impending cardiac arrest. This case highlights the differential diagnosis of angioedema and the management strategies for a difficult airway.

Indexed as

ace inhibitor-induced angioedemaace inhibitorsairway managementangioedemabradykinin-induced angioedemadelayed-onset angioedemadrug-induced angioedemafacial angioedema

Identifiers

PMID41646567
PMCPMC12871083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.